| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/29/2004 | WO2004007770A3 Method for diagnosis of intestinal-type gastric tumors |
| 04/29/2004 | WO2004007706A8 Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (nppase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants |
| 04/29/2004 | WO2004007553A8 Antibodies anti-c5 component of the complement system and their use |
| 04/29/2004 | WO2004005346A3 Human nuclear hormone receptor |
| 04/29/2004 | WO2004003185A3 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/29/2004 | WO2003104408A3 Commercial production of recombinant manganese-dependent peroxidase in plants |
| 04/29/2004 | WO2003104392A9 Improved reagents and methods for producing parvoviruses |
| 04/29/2004 | WO2003096869A3 Recombinant bet. v. 1. allergen mutants, methods and process thereof |
| 04/29/2004 | WO2003089622A3 Novel genes, compositions, and methods for modulating the unfolded protein response |
| 04/29/2004 | WO2003087408A3 Schizophrenia associated genes |
| 04/29/2004 | WO2003087368A3 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 04/29/2004 | WO2003087367A3 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 04/29/2004 | WO2003087341A3 Targeted chromosomal mutagenesis using zinc finger nucleases |
| 04/29/2004 | WO2003078604A3 Tobacco rattle virus vectors and related compositions and methods |
| 04/29/2004 | WO2003075840A3 Human antibodies specific to kdr and uses thereof |
| 04/29/2004 | WO2003074715A3 Process for the production of unsaturated fatty acids |
| 04/29/2004 | WO2003072054A3 Custom ligand design for biomolecular filtration and purification for bioseperation |
| 04/29/2004 | WO2003066828A3 Zinc finger libraries |
| 04/29/2004 | WO2003065973A3 Multivalent streptococcal vaccine compositions and methods for use |
| 04/29/2004 | WO2003060127A3 Genes and proteins involved in the biosynthesis of lipopeptides |
| 04/29/2004 | WO2003060087A3 Rapid method of selecting cells for gene disruption by homologous recombination |
| 04/29/2004 | WO2003057134A3 Specific binding agents of human angiopoietin-2 |
| 04/29/2004 | WO2003054170A8 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 04/29/2004 | WO2003051305A3 Innate immune system-directed vaccines |
| 04/29/2004 | WO2003042399A9 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 04/29/2004 | WO2003032913A9 Methods and compositions for targeting proteins across the blood brain barrier |
| 04/29/2004 | WO2003031623A8 Cocoa flavour precursor peptides |
| 04/29/2004 | WO2003025171A9 Modulation of retinoic acid receptor gene expression and therapeutic uses thereof |
| 04/29/2004 | WO2003020949A3 Targeted nucleic acid constructs and uses related thereto |
| 04/29/2004 | WO2003013537A9 Irinotecan for treatment of cancer |
| 04/29/2004 | WO2003013536A9 Methods for treatment of cancer using irinotecan based on ugt1a1 |
| 04/29/2004 | WO2003013535A9 Use of irinotecan for improved treatment of cancer based on mdr1 |
| 04/29/2004 | WO2003013534A9 Methods for the treatment of cancer with irinotecan based on cyp3a5 |
| 04/29/2004 | WO2003013533A9 Methods for improved treatment of cancer with irinotecan based on mrp1 |
| 04/29/2004 | WO2003010196A3 Variants and exons of the glyt1 transporter |
| 04/29/2004 | WO2003004683A3 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/29/2004 | WO2003004517A3 Peyers's patch and/or m-celle targeting ligands |
| 04/29/2004 | WO2003003006A3 New potent, selective and non toxic c-kit inhibitors |
| 04/29/2004 | WO2003000715A8 Chimeric histone acetyltransferase polypeptides |
| 04/29/2004 | WO2002103051A3 Nucleic acid triplex and quadruplex formation |
| 04/29/2004 | WO2002101004A3 Low-temperature cycle extension of dna with high priming specificity |
| 04/29/2004 | WO2002097082A8 Engineered biosynthesis of novel polyenes |
| 04/29/2004 | WO2002095021A3 A repressor-mediated regulation system for control of gene expression in plants |
| 04/29/2004 | WO2002072630A3 Nucleic acid-associated proteins |
| 04/29/2004 | WO2002070748A3 Response of dendritic cells to a diverse set of pathogens |
| 04/29/2004 | WO2002070721A8 Recombinant dimorphic fungal cell |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002061096A8 Determination of hydrophobic coenzyme a esters and other lipids using a biosens or comprising a modified coenzyme a- and acyl- binding protein (acbp) |
| 04/29/2004 | WO2002046372A9 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| 04/29/2004 | WO2002033067A8 Regulation of promoter activity using a polypeptide isolated from lactococcus lactis |
| 04/29/2004 | WO2002020804A8 Rat cathepsin, dipeptidyl peptidase i (dppi): crystal structure, inhibitors and its uses |
| 04/29/2004 | WO1999028440A9 Nucleic acid encoding mammalian ubr1 |
| 04/29/2004 | WO1991013987A3 Cdna coding for the gene n of the viral haemorrhagic septicaemia virus and utilizations thereof |
| 04/29/2004 | WO1991000348A3 Modified vp1/p2a regions of the rhinoviral system |
| 04/29/2004 | US20040083505 Translocation codon; genetic engineered plants; gene expression of protein; blocking virus infections |
| 04/29/2004 | US20040083504 Sequence regulating the anther-specific expression of a gene and its use in the production of androsterile plants and hybrid seeds |
| 04/29/2004 | US20040083503 Plants, seeds and oils having an elevated total monounsaturated fatty acid content |
| 04/29/2004 | US20040083501 Gene for disease resistance plant; transformation of plant using polynucleotide |
| 04/29/2004 | US20040083500 Compositions and methods to stack multiple nucleotide sequences of interest in the genome of a plant |
| 04/29/2004 | US20040083499 Processes and vectors for plastid transformation of higher plants |
| 04/29/2004 | US20040083498 Cloning method using oocytes matured in vivo |
| 04/29/2004 | US20040083496 Genetic engineered polypeptides; incubation, amplification |
| 04/29/2004 | US20040082773 Modified PAR receptors, their preparation and their uses for selecting compounds which modulate PAR activity |
| 04/29/2004 | US20040082770 Herbicide resistant, transgenic plants; genetic engineered polynucleotide |
| 04/29/2004 | US20040082763 Diagnosis, therapy of Alzheimer's disease; synthetic antibody |
| 04/29/2004 | US20040082758 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 04/29/2004 | US20040082534 Treatment of melanoma by reduction in clusterin levels |
| 04/29/2004 | US20040082532 Antifungal therapeutic targets |
| 04/29/2004 | US20040082531 Containing a transcription regulatory sequence derived from Human Cytomegalovirus major immediate early gene that includes exon 1, but not intron A; use of such vectors in vaccine and pharmaceutical compositions and gene therapy |
| 04/29/2004 | US20040082530 Nucleic acid immunization |
| 04/29/2004 | US20040082529 Treating or preventing cancer by administering to subject a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence |
| 04/29/2004 | US20040082515 Regulation of biological events using novel compounds |
| 04/29/2004 | US20040082512 Drugs for treatment of inflammation/blood brain barrier degradation |
| 04/29/2004 | US20040082507 Use of GLP-1 and GLP-2 peptides |
| 04/29/2004 | US20040082080 Activating sample with radiation; complexing target and detector; measurement fluorescence |
| 04/29/2004 | US20040082079 Solid support; detector; providing ligand library ; contacting target; determination, calibrating of binding |
| 04/29/2004 | US20040082064 Stimulanting immunology response; calibrating success of organ, tissue transplant; polymerase chain reaction analysis; administering immunosuppressants |
| 04/29/2004 | US20040082062 Method and medium for in vitro culture of human embryos |
| 04/29/2004 | US20040082053 Thermostable glutaminase and thermostable glutaminase gene |
| 04/29/2004 | US20040082050 Chorismate biosynthesis enzymes |
| 04/29/2004 | US20040082049 Method of screening compounds that inhibit lysophosphatidic acid acyltransferase |
| 04/29/2004 | US20040082040 Amino acid-producing bacteria and a process for preparing L-amino acids |
| 04/29/2004 | US20040082039 Immunoglobulin fusion proteins |
| 04/29/2004 | US20040082037 Antiproliferative agents of vascular smooth muscles |
| 04/29/2004 | US20040082035 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/29/2004 | US20040082034 Stable hairpin structure; promoter joining to nucleotide sequence |
| 04/29/2004 | US20040082031 Polypeptides; genetic engineering; antibodies; cardiovascular disorders, antiinflammatory agents, anticholesterol agents, antitumor agents |
| 04/29/2004 | US20040082028 Genetic engineering; three-dimensional construction; heat resistance; used for converting starch to sugar |
| 04/29/2004 | US20040082027 Conjugate of a tissue non-specific alkaline phosphatase and dextran, process for its production and use thereof |
| 04/29/2004 | US20040082025 Modified yeasts and uses thereof, in particular for producing steroid derivatives |
| 04/29/2004 | US20040082017 Protein for drug screening; purification of lysosomes; fusion protein; nucleotide sequence coding polypeptide; quantitative analysis |
| 04/29/2004 | US20040082014 Method and test system for identifying substances which protect nerve cells |
| 04/29/2004 | US20040082002 Genetic engineering; screening antagonist; medical diagnosis using antibodies |
| 04/29/2004 | US20040082001 Method and compositions for ordering restriction fragments |
| 04/29/2004 | US20040081999 Genetic engineered protein; controlling cell proliferation, cell differentiation |
| 04/29/2004 | US20040081998 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 04/29/2004 | US20040081997 Microfluidic devices and methods for performing temperature mediated reactions |
| 04/29/2004 | US20040081994 Measuring efficiency of exercise; measuring isotropic patterns; sensitivity to cardiovascular disorders |
| 04/29/2004 | US20040081993 Quantification of gene expression |
| 04/29/2004 | US20040081992 Controlling gene expression; cell differentiation; drug screening; complexing, measuring binding |